Bright Minds Biosciences, Inc. (DRUG)
89.41
+0.74
(+0.83%)
USD |
NASDAQ |
Jan 13, 16:00
89.11
-0.30
(-0.34%)
After-Hours: 20:00
Bright Minds Biosciences Market Cap: 870.16M for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 964.11B |
| NovaBay Pharmaceuticals, Inc. | 1.643B |
| Palatin Technologies, Inc. | 15.99M |
| Theriva Biologics, Inc. | 7.119M |
| Oragenics, Inc. | 0.7234M |
Market Cap Related Metrics
| PEG Ratio | -0.5027 |
| Price to Book Value | 14.76 |
| Price | 89.41 |
| Earnings Yield | -1.38% |
| PEGY Ratio | -0.5027 |